DEVON, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare ...
That search for answers would ultimately lead to genetic testing, where Robin and her family learned that Sam has a rare genetic condition known as Fragile X syndrome (FXS), caused by a change in the ...
In a comprehensive Genomic Press Interview, researchers from the University of Texas Health Science Center at San Antonio and Hirosaki University have uncovered critical new insights into the ...
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan ...
Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the leading cause of monogenic autism spectrum disorder and inherited ...
For 22 years, Jason Mazzola's life was defined by Fragile X, a genetic condition that often causes autism and intellectual disability. Jason, who is 24 now, needed constant supervision. He had ...
SPG601 is an investigational small molecule large-conductance, calcium-activated potassium channel activator. The Food and Drug Administration (FDA) has granted Fast Track designation to SPG601 for ...
ALBANY, N.Y. (NEWS10) — An Albany mother is working to help hundreds of medically fragile families across the state, including her own. With high care demands and in-home nursing shortages, Linda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback